Federal prime contract award
Recipient: INTERNATIONAL AIDS VACCINE INITIATIVE INC.
Awarding agency: Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
Description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE.  THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN
Award type: DEFINITIVE CONTRACT
Award amount: $95592504
Total outlays: $48556341
Period of performance: 2021-09-30 to 2028-12-31
NAICS: 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC: AN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
Place of performance (state): NY